Administration of vaccinia virus to mice may cause contact or bedding sentinel mice to test positive for orthopoxvirus antibodies: Case report and follow-up investigation

Comparative Medicine

Volumn 53, Issue 1, 2003, Pages 85-88

  Gaertner, Diane J ^a   Batchelder, Margaret ^a   Herbst, Lawrence H ^a   Kaufman, Howard L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ORTHOPOXVIRUS ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ECTROMELIA VIRUS; EXPERIMENTAL ANIMAL; FOLLOW UP; HEMAGGLUTINATION INHIBITION TEST; INOCULATION; MOUSE; MOUSE STRAIN; NONHUMAN; SEROCONVERSION; TAIL; VACCINIA VIRUS; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; VACCINIA VIRUS;

EID: 0344406154     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Long, L., R. T. Glover, and H. L. Kaufman. 1999. The next generation of vaccines for the treatment of cancer. Curr. Opin. Mol. Ther. 1:57-63.
2. Bhatt, P. N. and R. O. Jacoby. 1986. Mousepox: pathogenesis, diagnosis and rederivation, p. 557-570. In P. N. Bhatt, R. O. Jacoby, H. C. Morse III, and A. E. New (ed.), 1 Viral and mycoplasmal infections of laboratory rodents: effects on biomedical research. Academic Press, Orlando, Fla.
3. Lipman, N. S., S. Perkins, H. Nguyen, M. Pfeffer, and H. Meyer. 2000. Mousepox resulting from use of ectromelia virus-contaminated, imported mouse serum. Comp. Med. 50:426-435.
4. Wallace, G. D., R. M. Werner, P. L. Golway, D. M. Hernandez, D. W. Alling, and D. A. George. 1981. Epizootiology of an outbreak of mousepox at the National Institutes dichlorvos in the control of murine acariasis. Lab. Anim. 8:271-274.
5. Kaufman, H., J. Schlom, and J. Kantor. 1991. A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA). Int. J. Cancer 30:900-907.
6. Kaufman, H., J. B. Rao, K. R. Irvine, V. Bronte, S. A. Rosenberg, N. P. Restifo, and K. R. Irivine. 1999. Interleukin-10 enhances the therapeutic effectiveness of a recombinant pox-virus-based vaccine in an experimental murine tumor model. J. Immunother. 23:489-496.
7. Shek, W. 2000. Personal communication.
8. Paturzo, F. X. 2000. Personal communication.
9. Jacoby, R. O. and P. N. Bhatt. 1987. Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. II. Pathogenesis. Lab. Anim. Sci. 37:16-22.
10. Johnson, E. 2000. Personal communication.
11. Jacoby, R. O., P. N. Bhatt, E. A. Johnson, and F. X. Paturzo. 1983. Pathogenesis of vaccinia (IHD-T) virus infection in BALB/ cAnN mice. Lab. Anim. Sci. 33:435-441.
12. Fenner, F. 1990. Wallace P. Rowe Lecture: poxviruses of laboratory animals. Lab. Anim. Sci. 40:469-480.
13. Bhatt, P. M. and R. O. Jacoby. 1987. Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. III. Experimental transmission of infection and derivation of virus-free progeny from previously infected dams. Lab. Anim. Sci. 37:23-27.
14. Briody, B. A. 1959. Response of mice to ectromelia and vaccinia viruses. Bacteriol. Rev. 23:61-95.
15. Lee, M. S., J. M. Roos, L. C. McGuigan, K. A. Smith, N. Cormier, L. K, Cohen, B. E. Roberts, and L. G. Payne. 1992. Molecular attenuation of vaccinia virus: mutant generation and animal characterization. J. Virol. 66:2617-2630.
16. Fenner, F., R. Wittek, and K. R. Dumbell. 1989. Vaccinia virus: the tool for smallpox eradication, p 143-170. In F. Fenner, R. Wittek, and K. R. Dumbell (ed.), The orthopoxviruses. Academic Press, Inc., San Diego, Calif.
17. Gnat, M. F., M. Puhlmann, D. L. Bartlett, and H. R. Alexander, Jr. 1999. Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases. Ann. Surg. 230:352-360.
18. Chen, B., R. M. Timiryasova, P. Haghihat, M. L. Andres, E. H. Kajioka, R. Dutta-Roy, D. S. Gridley, and I. Fodor. 2001. Low-dose vaccinia virus-mediated cytokine gene therapy of glioma. J. Immunother. 24:46-57.
19. Roh, S., Y. K. Lee, B. Y. Ahn, K. Kim, and A. Moon. 2001. Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/d mice immunized with recombinant vaccinia viruses. Virus Res. 73:17-26.
20. Nishikawa, Y., X. Xuan, H. Nagasawa, I. Igarashi, K. Fujisaki, and H. Otsuka. 2001. Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene. Vaccine 19:1710-1716.
21. Dong, W., M. Li, H. Bi, Y. Li, J. Wu, and L. Qu. 2001. Assessment of a vaccinia virus vectored multi-epitopes live vaccine candidate for Plasmodium falciparum. Int. J. Parasitol. 31:57-62.
22. Kutinova, L., P. Hainz, V. Ludvikova, L. Maresova, and S. Nemeckova. 2001. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of Varicella zoster virus. Virology 280:211-220.